| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Matinas Biopharma Holdings, Inc. (MTNB) has 0 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. MTNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2020 | Stern Adam K | - | Buy | 20,000 | $0.83 | $16,600.00 | +0.6% | |
| May 14, 2020 | Lepore Patrick G | Director | Buy | 100,000 | $0.73 | $73,050.00 | +33.3% | |
| Mar 17, 2020 | Jabbour Jerome D | President And CEO | Buy | 10,000 | $0.65 | $6,500.00 | +1.3% | |
| Mar 17, 2020 | Stern Adam K | Director | Buy | 10,000 | $0.65 | $6,500.00 | New | |
| Nov 25, 2019 | Kucinski Keith A | Chief Financial Officer | Buy | 94,500 | $1.22 | $114,967.50 | +258.9% | |
| Nov 15, 2019 | Lepore Patrick G | Director | Buy | 100,000 | $1.06 | $105,530.00 | +50.0% | |
| Aug 20, 2019 | Ende Eric J81 | Director | Buy | 20,000 | $0.66 | $13,200.00 | +22.4% | |
| Aug 19, 2019 | Jabbour Jerome D | President And CEO | Buy | 14,650 | $0.68 | $9,975.19 | +1.9% | |
| Aug 19, 2019 | Stern Adam K | Director | Buy | 10,400 | $0.70 | $7,267.52 | +1.3% | |
| Aug 19, 2019 | Ende Eric J81 | Director | Buy | 20,000 | $0.68 | $13,650.00 | +28.9% |